ArticleJournal of the American College of Cardiology2025
Ensemble Deep Learning Algorithm for Structural Heart Disease Screening Using Electrocardiographic Images: PRESENT SHD.
Article in Journal of the American College of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Detection of Severe Structural Heart Disease Using an AI-Enhanced Portable 1-Lead ECG: The ACCESS-SHD Study.medRxiv : the preprint server for health sciences · 2026Article
- Artificial intelligence and the evolution of the electrocardiogram: from cardiovascular diagnostic tool to digital biomarker.European heart journal. Digital health · 2026Review
- Disease-focused evaluation of AI-ECG tools: clarifying study design, findings, and the principles of open science.European heart journal. Digital health · 2026Article
- Digital phenotyping of aortic stenosis-related remodeling reveals complementary structural, electrical, and hemodynamic signatures.medRxiv : the preprint server for health sciences · 2026Article
- Autonomous Agents for Auditable Cardiovascular Artificial Intelligence Development.medRxiv : the preprint server for health sciences · 2026Article
- Hidden in plain sight: AI-ECG triage in global telehealth networks.American journal of preventive cardiology · 2026Article
- Artificial intelligence-enabled electrocardiography to triage echocardiography for structural heart disease diagnosis in a low-resource setting.American journal of preventive cardiology · 2026Article
- The Evolving Utility of Artificial Intelligence-Based Tools for the Detection of Heart Failure and Cardiomyopathies: From Potential to Implementation.Current heart failure reports · 2026Review
- Emerging Artificial Intelligence Tools for the Screening of Structural and Valvular Heart Disease.Current heart failure reports · 2026Review
- Open science requires trust and rigour: a framework for responsible evaluation of shared AI-ECG tools.European heart journal. Digital health · 2026Article
- Wearable-Echo-FM: an ECG echo foundation model for 1-lead electrocardiography.European heart journal. Digital health · 2026Article
- Artificial Intelligence-Enabled ECG to Detect Congenitally Corrected Transposition of the Great Arteries.Pediatric cardiology · 2026Article
- Evaluation of artificial intelligence-based electrocardiogram analysis tools in patients with hypertrophic cardiomyopathy.European heart journal. Digital health · 2026Article
- Distributed Precision Stroke Care: Artificial Intelligence-Driven Stroke Management Using Multimodal Sensor Data.Stroke · 2026Review
- Article
- AI-ECG for Echocardiography Triage in Structural Heart Disease: Evidence, Implementation, and Future Directions.International journal of general medicine · 2026Review
- Feasibility of detecting aortic stenosis with mobile phone auscultation data: a pilot study.Frontiers in cardiovascular medicine · 2026Article
- Development and evaluation of an artificial intelligence-based electrocardiogram prediction model for emergency chest pain patients.Frontiers in medicine · 2026Article
- Reliability of Artificial Intelligence-enhanced Electrocardiography.medRxiv : the preprint server for health sciences · 2025Article
- Phenotypic Selectivity of Artificial Intelligence-Enhanced Electrocardiography in Cardiovascular Diagnosis and Risk Prediction.Circulation · 2025Article
Corrections and comments
- Update of
Authors and funding
13 authors.
Funding
Abstract
backgroundIdentifying structural heart diseases (SHDs) early can change the course of the disease, but their diagnosis requires cardiac imaging, which is limited in accessibility.
objectivesThe purpose of this study was to leverage images of 12-lead electrocardiograms (ECGs) for automated detection and prediction of multiple SHDs using an ensemble deep learning approach.
methodsWe developed a series of convolutional neural network models for detecting a range of individual SHDs from images of ECGs with SHDs defined by transthoracic echocardiograms performed within 30 days of the ECG at the Yale New Haven Hospital (YNHH). SHDs were defined as left ventricular ejection fraction <40%, moderate-to-severe left-sided valvular disease (aortic/mitral stenosis or regurgitation), or severe left ventricular hypertrophy (interventricular septal diameter at end-diastole >1.5 cm and diastolic dysfunction). We developed an ensemble XGBoost model, PRESENT-SHD (Practical scREening using ENsemble machine learning sTrategy for SHD detection), as a composite screen across all SHDs. We validated PRESENT-SHD at 4 U.S. hospitals and the prospective, population-based ELSA-Brasil (Brazilian Longitudinal Study of Adult Health) cohort, with concurrent protocolized ECGs and transthoracic echocardiograms. We also used PRESENT-SHD for risk stratification of new-onset SHD or heart failure (HF) in clinical cohorts and the population-based UK Biobank.
resultsThe models were developed using 261,228 ECGs from 93,693 YNHH patients and evaluated on a single ECG from 11,023 individuals at YNHH (19% with SHD), 44,591 across external hospitals (20%-27% with SHD), and 3,014 in the ELSA-Brasil (3% with SHD). In the held-out test set, PRESENT-SHD demonstrated an area under the receiver-operating characteristic curve (AUROC) of 0.886 (95% CI: 0.877-894), 90% sensitivity, and 66% specificity. At hospital-based sites, PRESENT-SHD had AUROCs ranging from 0.854 to 0.900, with sensitivities and specificities of 93% to 96% and 51% to 56%, respectively. The model generalized well to ELSA-Brasil (AUROC 0.853 [95% CI: 0.811-0.897], 88% sensitivity, 62% specificity). PRESENT-SHD demonstrated consistent performance across demographic subgroups, novel ECG formats, and smartphone photographs of ECGs from monitors and printouts. A positive PRESENT-SHD screen portended a 2- to 4-fold higher risk of new-onset SHD/heart failure, independent of demographics, comorbidities, and the competing risk of death across clinical sites and UK Biobank, with high predictive discrimination.
conclusionsWe developed and validated PRESENT-SHD, an AI-ECG tool identifying a range of SHD using images of 12-lead ECGs, representing a robust, scalable, and accessible modality for automated SHD screening and risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.